GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)

Title
GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1)
Authors
Keywords
CFTR modulator, Cystic fibrosis, Gating mutation, GLPG1837, G551D, Ivacaftor
Journal
Journal of Cystic Fibrosis
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-05-28
DOI
10.1016/j.jcf.2019.05.006

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started